-
How well-positioned is Orthofix for 2024?
With its SeaSpine merger sealed and a new leader at the helm, Orthofix had a busy 2023. Here's what to know going into next year: -
6 big deals shaking up the spine, orthopedic industry
Here are six major acquisitions Becker's has reported on since Sept. 1: -
4 things to know about Orthofix's new CEO
Massimo Calafiore was recently named as CEO of Orthofix, replacing an interim leader installed in September. Here are four things to know about him: -
How well-positioned is Globus Medical for 2024?
Following a more than $1 billion-revenue year in 2022, Globus Medical had high expectations for 2023. This year, the company completed a multibillion-dollar merger and surpassed previous quarterly earnings. -
M6-C disc superior to ACDF after 5 years: study
New data from Orthofix found its M6-C cervical disc saw better outcomes than anterior cervical discectomy and fusion after 5 years. -
Spinal Elements releases 3D-printed interbody portfolio
Spinal Elements launced its Ventana 3D-printed interbody portfolio, according to a Nov. 28 news release. -
Former NuVasive, LimaCorporate exec to lead Orthofix
Orthofix named Massimo Calafiore as its new president and CEO. -
28 spine devices receive FDA 510(k) approval in October
The Food and Drug Administration cleared 28 spine-related devices with 510(k) approval in October. -
6 medtech notes in 7 days
Here are six spine and orthopedic medtech updates that Becker's has reported on since Nov. 14: -
How well-positioned is Stryker for 2024?
Stryker in 2023 has seen continued revenue growth and made progress with its spine portfolio. -
16 Medtronic devices earning FDA clearance in 2023
Since the beginning of 2023, 16 new devices created by medical device company Medtronic have secured 510(k) clearance from the FDA, including several spinal and orthopedic devices. -
Medtronic sees $8B in Q2 sales for fiscal year 2024
Medtronic on Nov. 21 posted its financial results for the second quarter of the fiscal year 2024. -
Is spine still innovative?
The last few years have been tough on spine device companies. -
How well-positioned is ZimVie for 2024?
ZimVie in 2023 saw decreases in its revenue, but the company also saw milestones in its spine portfolio. -
CEO pay for top spine, orthopedic companies
The top executives at large orthopedic and spine device companies received millions of dollars in total compensation for the 2022 fiscal year, according to reports filed with the U.S. Securities & Exchange Commission. -
Boston Scientific completes $850M+ acquisition of spine company
Boston Scientific closed its acquisitioon of Relievant Medsystems, which is behind the Intracept intraosseous nerve ablation system, according to a Nov. 17 news release. -
Aurora Spine sales up 7.7% in Q3
Aurora Spine has announced its financial results for the third quarter of 2023, seeing a 7.7% growth in sales from the same quarter last year. -
Visie adds spine, orthopedic medtech leaders to team, board
Visie, a company focused spine and orthopedic imaging, added three medtech leaders to its board and leadership, according to a Nov. 14 news release. -
NGMedical GmbH's cervical disc replacement expands to Taiwan
NGMedical GmbH's Move-C device made its debut in Taiwan, according to a Nov. 14 news release. -
VySpine gets FDA clearance for new cervical fusion device
VySpine earned FDA clearance for its ClariVy OsteoVy PEKK device for one-level cervical interbody fusion, the company said in a Nov. 14 news release.
Page 17 of 199